| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | +34.50% | +4.00% | +30.50% | +30.50% | — |
| 14d | 1 | +100.00% | +31.45% | +5.47% | +25.98% | +25.98% | — |
| 30d | 1 | +100.00% | +18.20% | +2.52% | +15.68% | +15.68% | — |
| 60d | 1 | +100.00% | +101.75% | +7.87% | +93.88% | +93.88% | — |
| 90d | 1 | +100.00% | +127.23% | +12.09% | +115.14% | +115.14% | — |
| 180d | 1 | +100.00% | +148.62% | +14.09% | +134.53% | +134.53% | — |
| 1y | 1 | +100.00% | +50.80% | +20.68% | +30.13% | +30.13% | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| GANX GAIN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | Mar 24, 2026 | Mar 26, 2026 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | Mar 20, 2025 | Mar 21, 2025 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 271,325 | — | — | 271,325 | Jan 6, 2025 | Jan 7, 2025 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASE CFO and Interim CEO | 14,400 | $1.01 | $14.5K | 14,400 | Aug 9, 2024 | Aug 12, 2024 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | Apr 8, 2024 | Apr 8, 2024 ↗ | View → |